Earnings History Data for Salarius Pharmaceuticals, Inc. (SLRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals Inc. is a clinical-stage oncology company. It develops therapies for the treatment of cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. Salarius Pharmaceuticals Inc., formerly known as Flex Pharma Inc., is based in Houston, Texas.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-05-2022 AH 4:05 PM ET
(May 12)
SLRX Salarius Pharmaceuticals, Inc. 10.79 -0.13 0.00 -0.06 Salarius Pharmaceuticals GAAP EPS of -$0.13 misses by $0.04
[5/12/2022 4:13 PM]
0.1829 -0.04 
(-17.61%)
0.18 -0.04 
(-17.97%)
0.16 - 1.51 2,497,312 1,980,000 562,489
10-03-2022 AH 4:05 PM ET
(Mar 10)
SLRX Salarius Pharmaceuticals, Inc. 17.36 -0.09 -0.10 -0.10 Salarius Pharmaceuticals GAAP EPS of -$0.09 misses by $0.01
[3/10/2022 4:21 PM]
0.3690 -0.13 
(-26.20%)
0.45 -0.05 
(-10.00%)
0.33 - 1.66 1,466,880 660,000 248,258
04-11-2021 AH 4:05 PM ET
(Nov 4)
SLRX Salarius Pharmaceuticals, Inc. 37.86 -0.08 -0.09 -0.10 Salarius Pharmaceuticals EPS misses by $0.02
[11/4/2021 4:37 PM]
0.7572 -0.08 
(-9.33%)
0.84 0.0 
(0.57%)
0.64 - 3.50 1,424,866 570,000 3,115
05-08-2021 PM 8:00 AM ET
(Aug 5)
SLRX Salarius Pharmaceuticals, Inc. 36.71 -0.07 -0.06 -0.13 Salarius Pharmaceuticals EPS misses by $0.01, misses on revenue
[8/5/2021 7:39 AM]
0.8027 0.01 
(0.97%)
0.82 0.03 
(3.14%)
0.63 - 3.50 428,948 390,000 8,880
12-05-2021 AH 4:05 PM ET
(May 12)
SLRX Salarius Pharmaceuticals, Inc. 54.13 -0.06 0.00 -0.22 Salarius Pharmaceuticals EPS in-line, misses on revenue
[5/12/2021 4:25 PM]
1.22 0.07 
(6.09%)
1.15 0.0 
(0.00%)
0.63 - 3.50 1,348,322 710,000 19,685
18-03-2021 AH 4:05 PM ET
(Mar 18)
SLRX Salarius Pharmaceuticals, Inc. 72.35 -0.10 0.00 0.00 Salarius Pharmaceuticals EPS beats by $0.01, revenue in-line
[3/18/2021 4:12 PM]
1.55 0.05 
(3.26%)
1.50 0.0 
(0.00%)
0.56 - 3.50 1,706,499 1,530,000 14,447
11-11-2020 AH 4:05 PM ET
(Nov 11)
SLRX Salarius Pharmaceuticals, Inc. 14.07 -0.10 0.00 -1.04 Salarius Pharmaceuticals EPS in-line, beats on revenue
[11/11/2020 4:10 PM]
0.7377 -0.03 
(-3.42%)
0.78 0.02 
(2.12%)
0.56 - 4.98 329,755 118,267 11,704
12-08-2020 AH 4:05 PM ET
(Aug 12)
SLRX Salarius Pharmaceuticals, Inc. 22.93 -0.13 0.00 2.00 Salarius Pharmaceuticals EPS beats by $0.04, beats on revenue
[8/12/2020 4:14 PM]
1.03 -0.04 
(-3.74%)
1.10 0.03 
(2.80%)
0.56 - 13.50 95,650 425,817 5,159
14-05-2020 AH SLRX Salarius Pharmaceuticals, Inc. 12.03 -0.22 0.00 3.00 Salarius Pharmaceuticals EPS beats by $0.22, misses on revenue
[5/14/2020 4:12 PM]
0.8501 0.01 
(1.23%)
0.86 0.01 
(1.16%)
0.56 - 24.45 324,126 243,980 1,539